Temazepam and Posterior reversible encephalopathy syndrome - a phase IV clinical study of FDA data

Summary:

Posterior reversible encephalopathy syndrome is reported as a side effect among people who take Temazepam (temazepam), especially for people who are female, 60+ old, also take Coreg, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Posterior reversible encephalopathy syndrome when taking Temazepam. It is created by eHealthMe based on reports of 40,724 people who have side effects when taking Temazepam from the FDA, and is updated regularly.

What is Temazepam?

Temazepam has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 42,106 Temazepam users. Check the latest studies of Temazepam.

What is Posterior reversible encephalopathy syndrome?

Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss) is found to be associated with 470 drugs and 1,007 conditions by eHealthMe. Check the latest studies of Posterior reversible encephalopathy syndrome.

On Jul, 09, 2026

40,724 people reported to have side effects when taking Temazepam.
Among them, 12 people (0.03%) have Posterior reversible encephalopathy syndrome.

Could Temazepam cause Posterior reversible encephalopathy syndrome?

Among these 12 people:

What is the gender of people who have Posterior reversible encephalopathy syndrome when taking Temazepam? *

female: 81.82 %
male: 18.18 %

What is the age of people who have Posterior reversible encephalopathy syndrome when taking Temazepam? *

What are other drugs people take besides Temazepam? *

What are other side effects people have besides Posterior reversible encephalopathy syndrome? *

High Blood Pressure: 5 people, 41.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 4 people, 33.33%
Malignant Neoplasm Progression (cancer tumour came back): 3 people, 25.00%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Weakness: 3 people, 25.00%
Intraventricular Haemorrhage (intraventricular bleeding): 3 people, 25.00%
Encephalopathy (functioning of the brain is affected by some agent or condition): 2 people, 16.67%
Meningitis Aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed): 2 people, 16.67%
Hypophagia (reduced food intake): 1 person, 8.33%

What are the existing conditions these people have? *

Endometrial Cancer: 3 people, 25.00%
Multiple Myeloma (cancer of the plasma cells): 3 people, 25.00%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 16.67%
High Blood Pressure: 2 people, 16.67%
Asthma: 2 people, 16.67%
Barrett's Oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach): 2 people, 16.67%
Bone Pain: 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%
Agitation (state of anxiety or nervous excitement): 2 people, 16.67%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Temazepam and have Posterior reversible encephalopathy syndrome?

- Check whether Posterior reversible encephalopathy syndrome is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Temazepam:

Temazepam (42,106 reports)

Posterior reversible encephalopathy syndrome treatments and more:

Posterior reversible encephalopathy syndrome (9,125 reports)

How severe was Posterior reversible encephalopathy syndrome and when was it recovered:

Posterior reversible encephalopathy syndrome in Temazepam

Expand to all the drugs that have ingredients of temazepam:

Posterior reversible encephalopathy syndrome and drugs with ingredients of temazepam (13 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Temazepam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Posterior reversible encephalopathy syndrome:

Posterior reversible encephalopathy syndrome (470 drugs)

Browse all the conditions that are associated with Posterior reversible encephalopathy syndrome:

Posterior reversible encephalopathy syndrome (1,007 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Temazepam) and Temazepam (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.